Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Trial details
- Registry ID
- NCT06561048
- Drugs studied
- Belinostat, Pralatrexate, Soquelitinib